Mostrando 8 resultados de: 8
Filtros aplicados
Publisher
Nanomaterials(2)
Expert Opinion on Drug Discovery(1)
Frontiers in Aging Neuroscience(1)
International Journal of Molecular Sciences(1)
Journal of Nanobiotechnology(1)
Área temáticas
Farmacología y terapéutica(6)
Enfermedades(5)
Fisiología humana(2)
Medicina y salud(2)
Cirugía y especialidades médicas afines(1)
Área de conocimiento
Farmacología(2)
Nanopartícula(2)
Neurología(2)
Biología molecular(1)
Biomateriales(1)
Origen
scopus(8)
Benzodiazepines and Related Drugs as a Risk Factor in Alzheimer's Disease Dementia
ArticleAbstract: Benzodiazepines (BZDs) and Z-drugs are compounds widely prescribed in medical practice due to theirPalabras claves:Alzheimer's disease, benzodiazepines, COGNITION, dementia, RISK FACTORSAutores:Antoni Camins, Auladell C., Bulló M., Busquets O., Cano A., Castro-Torres R.D., Ettcheto M., Folch J., García M.L., Manzine P.R., Olloquequi J., Sanchez-Lopez E., Zárate C.B.Fuentes:scopusCurrent advances in the development of novel polymeric nanoparticles for the treatment of neurodegenerative diseases
ReviewAbstract: Effective intervention is essential to combat the coming epidemic of neurodegenerative (ND) diseasesPalabras claves:brain disorders, Brain targeting, CNS nanomedicine, neurodegenerative diseases, neurological diseases, Polymeric nanoparticlesAutores:Antoni Camins, Cano A., Espina M., Ettcheto M., Galindo R., García M.L., Lopez-Machado A.L., Sanchez-Lopez E., Souto E.M.B., Turowski P.Fuentes:scopusArticle dexibuprofen biodegradable nanoparticles: One step closer towards a better ocular interaction study
ArticleAbstract: Ocular inflammation is one of the most prevalent diseases in ophthalmology, which can affect variousPalabras claves:Dexibuprofen, Drug delivery system, Nanoparticles, PLGAAutores:Alsafi Z., Antoni Camins, Calpena A.C., Cano A., Espina M., Esteruelas G., Ettcheto M., García M.L., Muñoz M., Ortiz A., Prat J., Pujol M., Sanchez-Lopez E., Souto E.M.B.Fuentes:scopusEpigallocatechin-3-Gallate (EGCG) Improves Cognitive Deficits Aggravated by an Obesogenic Diet Through Modulation of Unfolded Protein Response in APPswe/PS1dE9 Mice
ArticleAbstract: Epigallocatechin-3-gallate (EGCG), a catechin found in green tea, has been previously investigated fPalabras claves:APPswe/PS1dE9 mice, Cognitive deficits, Epigallocatechin-3-gallate, hippocampus, obesity, unfolded protein responseAutores:Antoni Camins, Auladell C., Busquets O., Cano A., Castro-Torres R.D., Ettcheto M., Folch J., García M.L., Manzine P.R., Olloquequi J., Verdaguer E., Zárate C.B.Fuentes:scopusMetal-based nanoparticles as antimicrobial agents: An overview
ReviewAbstract: Metal-based nanoparticles have been extensively investigated for a set of biomedical applications. APalabras claves:AgNPs, Antibacterial activity, AuNPs, CuONPs, Metal-based nanoparticles, ZnONPsAutores:Antoni Camins, Bonilla L., Cano A., Durazzo A., Espina M., Esteruelas G., Ettcheto M., Galindo R., García M.L., Gomes D., Lopez-Machado A.L., Sanchez-Lopez E., Santini A., Silva A.M., Souto E.M.B.Fuentes:scopusRole of c-jun N-terminal kinases (JNKs) in epilepsy and metabolic cognitive impairment
ReviewAbstract: Previous studies have reported that the regulatory function of the different c-Jun N-terminal kinasePalabras claves:BRAIN, C-Jun-N-terminal kinase, cognitive impairment, Epilepsy, JNK inhibitor, metabolism, Type 2 DiabetesAutores:Antoni Camins, Auladell C., Busquets O., Cano A., Castro-Torres R.D., Espinosa-Jimenez T., Ettcheto M., Folch J., Manzine P.R., Olloquequi J., Sanchez-Lopez E., Sureda F.X., Verdaguer E., Zárate C.B.Fuentes:scopusState-of-the-art polymeric nanoparticles as promising therapeutic tools against human bacterial infections
ReviewAbstract: Infectious diseases kill over 17 million people a year, among which bacterial infections stand out.Palabras claves:Bacterial Infections, Infectious diseases, Nanomedicine, nanotechnology, Polymeric nanoparticlesAutores:Antoni Camins, Cajal Y., Cano A., Espina M., Ettcheto M., García M.L., Lopez-Machado A.L., Rabanal F., Sanchez-Lopez E., Souto E.M.B.Fuentes:scopusThe preclinical discovery and development of opicapone for the treatment of Parkinson’s disease
ArticleAbstract: Introduction: Opicapone (OPC) is a well-established catechol-O-methyltransferase (COMT) inhibitor thPalabras claves:dyskinesia, entacapone, Opicapone, Parkinson’s Disease, tolcaponeAutores:Antoni Camins, Auladell C., Busquets O., Cano A., Ettcheto M., Folch J., Manzine P.R., Olloquequi J., Sanchez-Lopez E., Verdaguer E.Fuentes:scopus